📰 Michael Yu News
Page 7 - Michael Yu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Yu. Real-time updates on events, politics, business and more.
June 21, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
June 15, 2022
HONG KONG, June 15, 2022 - (ACN Newswire) - On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced
June 15, 2022
Breakthrough Cooperation of Legend Capitals Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
June 14, 2022
SAN FRANCISCO and SUZHOU, China, June 14, 2022 /PRNewswire/ --Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and PT Etana Biotechnologies Indonesia ("Etana"), today jointly announced that the Indonesian Food and Drugs Authority (BPOM) has approved Bevagen (bevacizumab b...
June 1, 2022
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
May 23, 2022
The government is trying to rein in the competitive excesses of market capitalism.
May 7, 2022
CHRS earnings call for the period ending March 31, 2022.
April 26, 2022
/PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational...
April 26, 2022
New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2022 BEIJING, April 26, 2022 /PRNewswire/ - New Oriental Education & Technology... | April 26, 2022
March 30, 2022
/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...